X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5653) 5653
Book Review (1263) 1263
Publication (322) 322
Book Chapter (71) 71
Conference Proceeding (29) 29
Dissertation (10) 10
Magazine Article (9) 9
Paper (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Government Document (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4608) 4608
humans (3770) 3770
diabetes mellitus, type 2 - drug therapy (2086) 2086
male (1884) 1884
animals (1871) 1871
dipeptidyl-peptidase iv inhibitors - therapeutic use (1795) 1795
female (1428) 1428
hypoglycemic agents - therapeutic use (1289) 1289
type 2 diabetes (1238) 1238
endocrinology & metabolism (1125) 1125
middle aged (1041) 1041
diabetes (1035) 1035
dipeptidyl-peptidase iv inhibitors - pharmacology (1012) 1012
glucagon-like peptide-1 (1006) 1006
dipeptidyl peptidase 4 - metabolism (923) 923
pharmacology & pharmacy (913) 913
dipeptidyl peptidase-iv (901) 901
dipeptidyl peptidase iv (850) 850
aged (815) 815
dipeptidyl-peptidase iv inhibitors - adverse effects (730) 730
sitagliptin (725) 725
rats (721) 721
dipeptidyl-peptidase-iv (680) 680
mice (671) 671
adult (650) 650
adamantane - analogs & derivatives (637) 637
biochemistry & molecular biology (631) 631
treatment outcome (623) 623
glucose (618) 618
diabetes mellitus, type 2 - blood (589) 589
dipeptidyl-peptidase iv inhibitors - administration & dosage (547) 547
hypoglycemic agents - adverse effects (543) 543
analysis (529) 529
blood glucose - metabolism (513) 513
hypoglycemic agents (502) 502
sitagliptin phosphate (497) 497
metformin (490) 490
double-blind (485) 485
insulin (473) 473
glycemic control (469) 469
drug therapy, combination (466) 466
hypoglycemic agents - pharmacology (461) 461
dipeptidyl peptidase-4 inhibitor (454) 454
blood glucose - drug effects (452) 452
diabetes mellitus (441) 441
cd26 (426) 426
care and treatment (422) 422
vildagliptin (415) 415
hypoglycemic agents - administration & dosage (410) 410
dipeptidyl-peptidase iv inhibitors (398) 398
research (393) 393
type-2 diabetes-mellitus (389) 389
expression (385) 385
risk factors (383) 383
abridged index medicus (365) 365
peptides (362) 362
adamantane - therapeutic use (357) 357
metformin - therapeutic use (354) 354
chemistry, medicinal (338) 338
diabetes mellitus, type 2 - complications (334) 334
type 2 diabetes mellitus (331) 331
drug therapy (329) 329
internal medicine (327) 327
safety (325) 325
medicine, general & internal (324) 324
glp-1 (318) 318
dpp-4 inhibitor (315) 315
medicine, research & experimental (313) 313
glycated hemoglobin a - metabolism (312) 312
diabetes mellitus, type 2 - metabolism (310) 310
peptidase (305) 305
triazoles - therapeutic use (304) 304
diabetes therapy (302) 302
dextrose (301) 301
beta-cell function (298) 298
pyrazines - therapeutic use (298) 298
dipeptidyl peptidase 4 (297) 297
efficacy (296) 296
dipeptidyl peptidase-4 inhibitors (293) 293
inhibitors (292) 292
glucagon (277) 277
linagliptin (275) 275
cell biology (270) 270
dipeptidyl-peptidase iv inhibitors - chemistry (267) 267
health aspects (267) 267
double-blind method (265) 265
proteins (261) 261
dose-response relationship, drug (260) 260
pyrrolidines - therapeutic use (252) 252
time factors (251) 251
physiological aspects (248) 248
mellitus (247) 247
cardiac & cardiovascular systems (244) 244
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (243) 243
immunology (243) 243
therapy (242) 242
dipeptidyl peptidase 4 - chemistry (241) 241
improves glycemic control (241) 241
enzymes (236) 236
nitriles - therapeutic use (235) 235
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5468) 5468
Japanese (53) 53
German (48) 48
French (42) 42
Spanish (29) 29
Chinese (23) 23
Korean (20) 20
Russian (14) 14
Hungarian (13) 13
Polish (10) 10
Czech (9) 9
Italian (7) 7
Croatian (4) 4
Danish (3) 3
Portuguese (3) 3
Dutch (2) 2
Turkish (2) 2
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE REVIEWS CANCER, ISSN 1474-175X, 10/2007, Volume 7, Issue 10, pp. 800 - 808
Proteases have long been associated with cancer progression because of their ability to degrade extracellular matrices, which facilitates invasion and... 
CELL LUNG-CANCER | MATRIX METALLOPROTEINASES | PROMOTER HYPERMETHYLATION | ONCOLOGY | HUMAN MACROPHAGE METALLOELASTASE | PROSTATE-SPECIFIC ANTIGEN | GENE-EXPRESSION | SERINE-PROTEASE | HUMAN BREAST-CANCER | NF-KAPPA-B | DIPEPTIDYL PEPTIDASE-IV
Journal Article
Chemical science, ISSN 2041-6520, 2010, Volume 1, Issue 1, pp. 13 - 31
The utility of copper-mediated cross-coupling reactions has been significantly increased by the development of mild reaction conditions and the ability to... 
Journal Article
Chemical Science, ISSN 2041-6520, 6/2010, Volume 1, Issue 1, pp. 13 - 31
The utility of copper-mediated cross-coupling reactions has been significantly increased by the development of mild reaction conditions and the ability to... 
NITROGEN-CONTAINING HETEROCYCLES | CROSS-COUPLING REACTIONS | ULLMANN-TYPE SYNTHESIS | AMINO-ACID | SULFINIC ACID SALTS | DIPEPTIDYL-PEPTIDASE-IV | C-N | ARYL HALIDES | N BOND FORMATION | HIGHLY EFFICIENT SYNTHESIS | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
KIDNEY INTERNATIONAL, ISSN 0085-2538, 09/2015, Volume 88, Issue 3, pp. 479 - 489
Integrin beta 1 and dipeptidyl peptidase (DPP)-4 play roles in endothelial cell biology. Vascular endothelial growth factor (VEGF)-A inhibits... 
CELLS | Flt1 | BETA-1-INTEGRIN | DIPEPTIDYL-PEPTIDASE-IV | Flk1 | smad3 | RENAL FIBROSIS | GROWTH-FACTOR-BETA | KIDNEY FIBROSIS | CD29 | MOUSE MODEL | UROLOGY & NEPHROLOGY | CD26 | MICE | STREPTOZOTOCIN | DIABETIC GLOMERULOPATHY | EndMT
Journal Article
12/2010
Objective : The aim of this study was to evaluate the dipeptidyl peptidase-IV (DPP-IV) inhibitor sitagliptin with respect to mode of inhibition and its in vivo... 
fast binding inhibitor | sitagliptin | vildagliptin | Dipeptidyl peptidase-IV | type 2 diabetes mellitus
Web Resource
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus | Abridged Index Medicus
Journal Article